| 注册
首页|期刊导航|临床肝胆病杂志|骨髓巨噬细胞M2亚型共培养后的骨髓间充质干细胞移植治疗肝硬化大鼠模型的效果分析

骨髓巨噬细胞M2亚型共培养后的骨髓间充质干细胞移植治疗肝硬化大鼠模型的效果分析

郑欣瑞 陈佳美 刘平 慕永平 许燕楠 王丹阳 邢飞飞 宗梦瑶 张士豪 战俊邑 刘伟 陈高峰

临床肝胆病杂志2024,Vol.40Issue(1):96-103,8.
临床肝胆病杂志2024,Vol.40Issue(1):96-103,8.DOI:10.12449/JCH240117

骨髓巨噬细胞M2亚型共培养后的骨髓间充质干细胞移植治疗肝硬化大鼠模型的效果分析

Therapeutic effect of transplantation of bone marrow mesenchymal stem cells co-cultured with bone marrow M2 macrophages on a rat model of liver cirrhosis

郑欣瑞 1陈佳美 1刘平 1慕永平 1许燕楠 1王丹阳 1邢飞飞 1宗梦瑶 1张士豪 1战俊邑 1刘伟 1陈高峰1

作者信息

  • 1. 上海中医药大学附属曙光医院,上海市中医药研究院肝病研究所,肝肾疾病病证教育部重点实验室,上海市中医临床重点实验室,上海 201203
  • 折叠

摘要

Abstract

Objective To investigate the effect of transplantation of bone marrow mesenchymal stem cells(BMSCs)co-cultured with bone marrow-derived M2 macrophages(M2-BMDMs),named as BMSCM2,on a rat model of liver cirrhosis induced by carbon tetrachloride(CCl4)/2-acetaminofluorene(2-AAF).Methods Rat BMDMs were isolated and polarized into M2 phenotype,and rat BMSCs were isolated and co-cultured with M2-BMDMs at the third generation to obtain BMSCM2.The rats were given subcutaneous injection of CCl4 for 6 weeks to establish a model of liver cirrhosis,and then they were randomly divided into model group(M group),BMSC group,and BMSCM2 group,with 6 rats in each group.A normal group(N group)with 6 rats was also established.Since week 7,the model rats were given 2-AAF by gavage in addition to the subcutaneous injection of CCl4.Samples were collected at the end of week 10 to observe liver function,liver histopathology,and hydroxyproline(Hyp)content in liver tissue,as well as changes in the markers for hepatic stellate cells,hepatic progenitor cells,cholangiocytes,and hepatocytes.A one-way analysis of variance was used for comparison of continuous data between multiple groups,and the least significant difference t-test was used for further comparison between two groups.Results Compared with the N group,the M group had significant increases in the activities of serum alanine aminotransferase(ALT)and aspartate aminotransferase(AST)(P<0.01);compared with the M group,the BMSC and BMSCM2 groups had significant reductions in ALT and AST(P<0.01),and the BMSCM2 group had significantly better activities than the BMSC group(P<0.05).Compared with the N group,the M group had significant increases in Hyp content and the mRNA and protein expression levels of alpha-smooth muscle actin(α-SMA)in the liver(P<0.01);compared with the M group,the BMSC and BMSCM2 groups had significant reductions in Hyp content and the expression of α-SMA(P<0.05),and the BMSCM2 group had a significantly lower level of α-SMA than the BMSC group(P<0.01).Compared with the N group,the M group had significant increases in the mRNA expression levels of the hepatic progenitor cell markers EpCam and Sox9 and the cholangiocyte markers CK7 and CK19(P<0.01)and significant reductions in the expression levels of the hepatocyte markers HNF-4α and Alb(P<0.01);compared with the M group,the BMSC and BMSCM2 groups had significant reductions in the mRNA expression levels of EpCam,Sox9,CK7,and CK19(P<0.05)and significant increases in the mRNA expression levels of HNF-4α and Alb(P<0.05),and compared with the BMSC group,the BMSCM2 group had significant reductions in the mRNA expression levels of EpCam and CK19(P<0.05)and significant increase in the expression level of HNF-4α(P<0.05).Conclusion M2-BMDMs can enhance the therapeutic effect of BMSCs on CCl4/2-AAF-induced liver cirrhosis in rats,which provides new ideas for further improving the therapeutic effect of BMSCs on liver cirrhosis.

关键词

肝硬化/间质干细胞/巨噬细胞/大鼠,Wistar

Key words

Liver Cirrhosis/Mesenchymal Stem Cells/Macrophages/Rats,Wistar

引用本文复制引用

郑欣瑞,陈佳美,刘平,慕永平,许燕楠,王丹阳,邢飞飞,宗梦瑶,张士豪,战俊邑,刘伟,陈高峰..骨髓巨噬细胞M2亚型共培养后的骨髓间充质干细胞移植治疗肝硬化大鼠模型的效果分析[J].临床肝胆病杂志,2024,40(1):96-103,8.

基金项目

国家自然科学基金面上项目(81874390) (81874390)

上海市科委自然科学基金面上项目(21ZR1464100) (21ZR1464100)

上海市科委2022年度"科技创新行动计划"生物医药科技支撑专项(22S11901700) (22S11901700)

上海市临床重点专科建设项目(shslczdzk01201) National Natural Science Foundation of China(81874390) (shslczdzk01201)

Shanghai Natural Science Foundation(21ZR1464100) (21ZR1464100)

Special Project for Biomedical Science and Technology Support of the"Science and Technology Innovation Action Plan"of Shanghai Science and Technology Commission in 2022(22S11901700) (22S11901700)

Shanghai Key Specialty of Traditional Chinese Clinical Medicine(shslczdzk01201) (shslczdzk01201)

临床肝胆病杂志

OA北大核心CSTPCD

1001-5256

访问量0
|
下载量0
段落导航相关论文